AGA Abstracts 538 Hara et al DDW 2021

Cheng Curr Opin Gastroenterol 2013 Proton pump inhibitors for eosinophilic oesophagitis

Cheng et al Gut 2013 Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD

Dellon ES et al Clin Gastroenterol Hepatol 2022 Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for EoE RCT

Dellon ES et al Clin Gastroenterol Hepatol Rapid recurrence of EoE activity after successful treatment

Dellon et al Gasteroenterology 2019 Efficacy of budesonide vs fluticasone for initial treatment of EoE in a RCT

Dellon et al N Engl J Med 2022 Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Dellon et al N Engl J Med 2022 Dupiluman in adults and adolescents with EoE Research summary

Eluri et al Clin Gastroenterol Hepatol 2019 Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment EoE

Eluri et al Curr Opin Gastroenterol 2015 Proton pump inhibitor-responsive oesophageal eosinophilia and EoE More similarities than differences

Greuter et al J Allergy Clin Immunol 2020 Emerging therapies for eosinophilic esophagitis

Gupta et al CMAJ 2024 Diagnosis and management of EoE

Hirano et al Clin Gastroenterol Hepatol 2022 BOS improves outcomes in patients with EoE Results from a phase 3 trial

Hirano et al Gastroenterology 2019 RPC4046 a monoclonal antibody against IL13 reduces histologic and endoscopic activity in patients with EoE

Hirano et al Gastroenterology 2020 AGA institute and joint task force on allergy___mgmt of EoE

Hirano et al Gastroenterology 2020 Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis

Hirano et al Gastroenterology 2020 Efficacy of dupiluman in a phase 2 RT of adults with activie EoE

Image Hirano et al 2020 AGA Task force Treatment algorithm

Lucendo et al Gastroenterol 2019 Efficacy of budesonide orodispersible tablets as induction therapy for EoE in a RCT

Maoyyedi et al Gastroenterology 2019 Safety of PPIs based on a large multiyear randomized trial of patients receiving rivaroxaban or aspirin

Molina-Infante et al Gut 2016 Proton pump inhibitor-responsive oesophageal eosinophilia An entity challenging current diagnostic criteria for EoE

Molina-Infante et al Gut 2017 PPI-REE Task Force of the EUREOS Clarifying misunderstandings and misinterpretations about PPI-responsive EoE

Muir et al JAMA 2021 Eosinophilic esophagitis A review

Pfefferlé et al Allergy 2024 An algorithm for the diagnosis and treatment of eosinophilic esophagitis in adults 2024

Picture1 Gastoenterology 2020 Budesonide orodispersible tablets

Rank et al Gastroenterology 2020 Technical review on the mgmt of EoE A report from the AGA Institute and Joint Task Force

Rochman et al J Allergy Clin Immunol 2021 Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors

Runge et al Dis Esophagus 2017 Control of inflammation decreases the need for subsequent esophageal dialation in patients with EoE

Staumann et al Gastroenterology 2020 Budesonide orodispersible tablets maintain remission in RCT EoE

Straumann et al Gastroenterology 2020 Figure gr2_lrg

Vaezi et al Gastroenterology 2017 Complications of Proton Pump Inhibitor Therapy Gastroenterology

Vaezi et al Gastroenterology 2020 Figure 1

Wechsler et al J Allergy Clin Immunol 2018 Biological therapies for eosinophilic gastrointestinal diseases

Wen et al J Allergy Clin Immunol 2015 Transcriptome analysis of PPI responsive EoE__inflammation

Dellon et al Am J Gastroenterol 2025 ACG Clinical Guideline Diagnosis and management of eosinophilic esophagitis